PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

COVID-19 studies are bolstered by lung cells made from induced pluripotent stem cells

COVID-19 studies are bolstered by lung cells made from induced pluripotent stem cells
2021-06-21
(Press-News.org) Durham, NC - A team led by researchers at Newcastle University, UK has successfully created a model of the cells found in the lungs that can be used to replicate how COVID-19 infects the airways. This information, reported today in the STEM CELLS journal, paves the way for broader studies of viral lung infections using a cost-effective system that can easily be manufactured on a large scale.

COVID-19, which to date has resulted in more than 3.5 million deaths worldwide, has brought on an urgent need for airway models that can be used to develop effective therapies. While the use of in vitro (outside the body) models generated from primary pulmonary epithelial cells that mimic the human airways has increased in popularity over recent years, their availability is limited to primary samples that can differ significantly depending on the various donors' genetic backgrounds.

Induced pluripotent stem cells (iPSCs) offer a potential way around this drawback. Generated from adult stem cells found in fat, skin, blood and elsewhere, they can be reprogrammed to become every other cell type in the body, including those making up the airways. Additionally, iPSCs can propagate indefinitely and, thus, provide a large supply of cells with the genetic background of a single donor, rather than the varied backgrounds of the multiple donors hindering primary pulmonary epithelial cell models.

In the study reported in STEM CELLS, airway epithelial cells were generated from iPSCs (using a mixed population of lung progenitors) by culturing them on a polyester membrane to allow formation of a confluent monolayer, then exposing them to an air liquid interface to induce differentiation into a pseudostratified epithelial model.

The researchers then went on to demonstrate that their model is composed of the cell types found in the human upper airway epithelium -- including functional ciliated cells -- and that the cells are capable of secreting mucus and of being readily infected by SARS-CoV-2, the virus that causes COVID-19.

"The infected model cells also secreted cytokines at levels corresponding to the behavior of the airway epithelium in the body following SARS-CoV-2 infection," said Lyle Armstrong, Ph.D., professor of stem cell sciences at Newcastle University, UK and corresponding author on the study. (Cytokines are proteins that signal the immune system to take action during an infection.)

"Our protocol not only simplifies the manufacture of cellular models of the human upper airways," he added, "but it has a distinct advantage in that we have eliminated the need for primary samples that differ in genetic backgrounds. Our next step will be to expand on this model by including immune cell components."

"The development of this reproducible and highly scalable protocol to manufacture upper airway models is very important for the study of respiratory viral infections such as SARS-CoV-2 and others," said Dr. Jan Nolta, Editor-in-Chief of STEM CELLS. "Having such models available will greatly enhance the development of future therapies and will allow the field to be better prepared to study new viruses and viral variants."

INFORMATION:

The full article, "SARS-CoV-2 infects an upper airway model derived from induced pluripotent stem cells," can be accessed at https://stemcellsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/stem.3422. About the Journal: STEM CELLS, a peer reviewed journal published monthly, provides a forum for prompt publication of original investigative papers and concise reviews. The journal covers all aspects of stem cells: embryonic stem cells/induced pluripotent stem cells; tissue-specific stem cells; cancer stem cells; the stem cell niche; stem cell epigenetics, genomics and proteomics; and translational and clinical research. STEM CELLS is co-published by AlphaMed Press and Wiley.

About AlphaMed Press: Established in 1983, AlphaMed Press with offices in Durham, NC, San Francisco, CA, and Belfast, Northern Ireland, publishes three internationally renowned peer-reviewed journals with globally recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines. STEM CELLS® is the world's first journal devoted to this fast paced field of research. THE ONCOLOGIST® is devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care. STEM CELLS TRANSLATIONAL MEDICINE® is dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and clinical trials, SCTM will help move applications of these critical investigations closer to accepted best practices.

About Wiley: Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical and scholarly journals, combined with our digital learning, assessment and certification solutions, help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 200 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at http://www.wiley.com.


[Attachments] See images for this press release:
COVID-19 studies are bolstered by lung cells made from induced pluripotent stem cells

ELSE PRESS RELEASES FROM THIS DATE:

Study charts 60 years of treatments, health characteristics among people with dwarfism

2021-06-21
In a retrospective study believed to be one of the largest of its kind, researchers say they have successfully charted the health risks, growth patterns, and medical and surgical outcomes of 1,374 people with the most common form of dwarfism, called achondroplasia, seen over a 60-year period at four academic medical centers, including Johns Hopkins Medicine. The findings, according to the researchers, not only affirm some long-standing views and trends in the care of those with the condition, but also offer a standardized baseline, a blueprint investigators hope will serve to speed diagnosis and improve patients' quality of life and health. Achondroplasia is caused by a rare genetic mutation that alters the activity of the fibroblast growth factor receptor 3 (FGFR3) gene involved in bone ...

New geochemical study confirms cause of end-Permian mass extinction event

New geochemical study confirms cause of end-Permian mass extinction event
2021-06-21
The most severe mass extinction event in the past 540 million years eliminated more than 90 percent of Earth's marine species and 75 percent of terrestrial species. Although scientists had previously hypothesized that the end-Permian mass extinction, which took place 251 million years ago, was triggered by voluminous volcanic eruptions in a region of what is now Siberia, they were not able to explain the mechanism by which the eruptions resulted in the extinction of so many different species, both in the oceans and on land. Associate professor Laura Wasylenki of Northern Arizona ...

Catherine F. Sinclair, MD appointed incoming Editor-in-Chief of VideoEndocrinology™

Catherine F. Sinclair, MD appointed incoming Editor-in-Chief of VideoEndocrinology™
2021-06-21
Alexandria, VA, and New Rochelle, NY, June 17, 2021--Catherine F. Sinclair, MD, has been appointed the next Editor-in-Chief of VideoEndocrinology™, published by Mary Ann Liebert, Inc. "I am honored and delighted to have been selected as the next EIC of VideoEndocrinology. I look forward to helping promote novel concepts and techniques in thyroidology and to assisting the wider community in navigating the rapidly evolving landscape of surgical and non-surgical management options for thyroid disease. I eagerly anticipate the opportunity to work with colleagues from multiple disciplines to showcase ...

Plant probes make sense for sustainable farming

Plant probes make sense for sustainable farming
2021-06-21
A method for making ultrathin sensors for monitoring the health of crops could help farmers grow more food without putting extra demands on the land. Intensive agriculture is already contributing to widespread biodiversity loss and climate change, yet growing populations continue to put pressure on farmers to produce more food. The challenge now lies in increasing agricultural output without clearing more land or applying excessive fertilizers. Precision farming is a promising solution that involves real-time monitoring of plant needs and responding to them with just the right amount of water, light or nutrients. "Precision farming typically relies on soil-based sensors or drones fitted with special cameras," says Ph.D. student Abdullah ...

Keeping a vigilant watch on SARS-CoV-2

2021-06-21
A SARS-CoV-2 lateral flow test that combines two bacterial enzymes with genetic sequences and a couple of probes is cheaper and easier to use than PCR tests while producing comparably reliable results. Called Vigilant and designed at KAUST, the test can detect very small amounts of viral RNA in a sample. "Several types of lateral flow tests are currently available or under research for detecting SARS-CoV-2," says KAUST Ph.D. student Tin Marsic. "Depending on how they work, they all have disadvantages, including detecting the virus only several days after infection or producing false positive and false negative results." PCR tests, which are conducted in laboratories, produce more reliable results but are expensive and require sophisticated ...

Understanding the impact of medical cannabis on kids, a meta-analysis

2021-06-21
In recent years, the use of medical cannabis to treat sick kids is on the rise, although questions remain about the benefits and safety of such treatments. Now, a team of researchers from the Hebrew University of Jerusalem (HU) has completed a first-ever meta-analysis of pediatric patients treated with medical cannabis to better understand the risks and benefits of cannabis use among young patients. The meta-review was led by Professor Ilan Matok at HU's School of Pharmacy and the David R. Bloom Center for Pharmacy, along with and PhD candidate Nir Treves. They will present their findings at the 31st Annual International Cannabinoid Research Society Symposium (ICRS) being held in ...

The risks of adopting 'body positivity' to make a sale

2021-06-21
COLUMBUS, Ohio - Instagram users who detect self-promotion or corporate marketing in a post embracing the body positivity movement may be turned off by that dual messaging, new research suggests. In the study, women viewed experimental Instagram posts that borrowed body positive messages from actual users and contained body positive hashtags, such as #bopo. The posts all featured the same initial body positive sentiment, but some posts also asked viewers to either like and follow their profiles and others advertised products or services. Researchers found that participants who spotted self-promotion or advertising considered the posts less morally appropriate and not altogether sincere in their support of the body positivity movement ...

Sleep apnea worsens heart disease, yet often untreated

2021-06-21
DALLAS, June 21, 2021 — Health care experts urge increased awareness of obstructive sleep apnea among people with cardiovascular disease or risk factors such as high blood pressure, according to a new scientific statement from the American Heart Association, published today in Circulation, the Association’s flagship journal. Obstructive sleep apnea (OSA) occurs in 40% to 80% of people with cardiovascular disease, yet it is under-recognized and undertreated, according to the statement. OSA occurs when an upper airway obstruction causes repeated episodes of disrupted breathing during sleep. Symptoms include snoring, lapses in breathing, fragmented sleep and daytime sleepiness. In general, about 34% of middle-aged men and 17% of middle-aged women meet ...

Some blood pressure-lowering meds linked to less memory decline in older adults

2021-06-21
DALLAS, June 21, 2021 — Older adults taking blood pressure-lowering medications known to cross the blood-brain barrier had better memory recall over time compared to those taking other types of medicines to treat high blood pressure, according to new research published today in the American Heart Association journal Hypertension. High blood pressure, or hypertension, is a risk factor for cognitive decline and dementia in older adults. Nearly half of American adults have elevated blood pressure. Treating high blood pressure with blood pressure-lowering medicines reduced the cases ...

Stanford researchers develop new software for designing sustainable cities

2021-06-21
New technology could help cities around the world improve people's lives while saving billions of dollars. The free, open-source software developed by the Stanford Natural Capital Project creates maps to visualize the links between nature and human wellbeing. City planners and developers can use the software to visualize where investments in nature, such as parks and marshlands, can maximize benefits to people, like protection from flooding and improved health. "This software helps design cities that are better for both people and nature," said Anne Guerry, Chief Strategy Officer and Lead Scientist at the Natural Capital Project. "Urban nature is a multitasking benefactor - the trees ...

LAST 30 PRESS RELEASES:

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

[Press-News.org] COVID-19 studies are bolstered by lung cells made from induced pluripotent stem cells